why choose us

First received: January 09, 2023

Clinical Trial: A Study of TAK-861 in Participants With Narcolepsy Type 1

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Narcolepsy Type 1

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)

Brief Summary: The main aim of this study is to see how TAK-861 works on symptoms of narcolepsy, including excessive daytime sleepiness and cataplexy.Approximately 100 participants will take part in the study across North America, Europe and Asia Pacific.The treatment (TAK-861 or placebo) will be administered for 8 or 12 weeks.After this treatment period the participant will have the option to participate in a separate, long- term extension study during which all participants will be treated with TAK-861.

Read more